688192 迪哲医药
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产337,672-1.07%341,32920,36122,09612,338
在建工程0--0169,72413,3478,855
无形资产388,160-2.09%396,433429,849461,979492,024
商誉0--0000
其他非流动资产80,859-1.50%82,09099,83188,59595,513
806,691-1.61%819,852719,765586,017608,730

流动资产
货币资金223,697-23.24%291,422250,16574,202121,674
应收账款170,99019.21%143,44127,49548,0400
存货32,137-13.02%36,94944,11523,4715,069
其他流动资产1,779,5064.01%1,710,865677,198764,6491,346,435
2,206,3291.08%2,182,677998,973910,3611,473,178

流动负债
短期借款108,955-49.89%217,453373,827200,1150
应付票据0--0000
应付帐款157,713-25.55%211,840139,087108,932152,865
其他流动负债515,691-7.24%555,940272,171139,38895,630
782,359-20.59%985,234785,085448,436248,495
流动资产净值1,423,97018.92%1,197,443213,888461,9261,224,683
资产总额减流动负债2,230,66110.58%2,017,295933,6531,047,9431,833,413

非流动负债
长期借款966,14240.40%688,147683,762138,3130
应付债券0--0000
其他非流动负债29,338-12.31%33,45749,83561,00274,932
995,48037.95%721,604733,596199,31674,932

总权益
    实收股本464,6330.75%461,188417,648408,151407,160
    储备项目769,859-7.54%832,670(223,892)440,4761,351,321
股东权益1,234,493-4.59%1,293,858193,756848,6271,758,481
非控股权益688-62.47%1,8336,30100